Vectorite Biomedical Inc. announced earnings results for the half year ended June 30, 2019. For the half year, the company announced sales was TWD 12.216 million compared to TWD 139.756 million a year ago. Operating loss was TWD 37.455 million compared to TWD 26.912 million a year ago. Net loss was TWD 37.124 million compared to TWD 25.804 million a year ago. Basic loss per share was TWD 0.88 compared to TWD 0.61 a year ago.